Sniff your way to recovery? nasal spray tested for COVID-19
Disease control
Terminated
This study tested a nasal spray called AD17002 to see if it could help adults with mild to moderate COVID-19 get better faster. About 180 participants were randomly assigned to receive either a placebo or one of two doses of the spray, in addition to standard care. The main goals…
Phase: PHASE2, PHASE3 • Sponsor: Advagene Biopharma Co. Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC